Skip to content
Screener

Fulgent Genetics, Inc. FLGT Laboratory Services — D&A

Other segment segments

Therapeutic Development
$143K-12.8%

Similar metrics at other companies

Consolidated Water Company logo
CWCOServices — D&A
$62.75K-61.0%
Transcat logo
TRNSService — D&A
$5.15M+36.3%
Deere & Company logo
DEFinancial Services — D&A
$272M+3.0%
APO
APOGArchitectural Services — D&A
$898.25K-9.7%
The Ensign Group logo
ENSGSkilled Services — D&A
$15.45M+12.3%
Trinity Industries logo
TRNLeasing & Services — D&A
$64.4M-4.5%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$526.64M-16.5%
Enterprise value$511.45M-6.7%
P/S1.6×-0.4×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 7:08 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-199065
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Laboratory services$5,857$5,755
Therapeutic development143164
Total$6,000$5,919

Item 1. Financial Statements.

FAQ

What is Fulgent Genetics, Inc.'s laboratory services — D&A?
Fulgent Genetics, Inc. (FLGT) reported laboratory services — D&A of $5.86M in Q1 2026.
How has Fulgent Genetics, Inc.'s laboratory services — D&A changed year-over-year?
Fulgent Genetics, Inc.'s laboratory services — D&A increased by 1.8% year-over-year, from $5.76M to $5.86M.
What is the long-term trend for Fulgent Genetics, Inc.'s laboratory services — D&A?
Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s laboratory services — D&A has grown at a 21.0% compound annual growth rate (CAGR), from $11M to $23.55M.
What does laboratory services — D&A mean?
This metric represents the systematic allocation of the cost of tangible and intangible assets used in the laboratory services segment over their useful lives. It is a non-cash charge that reflects the wear and tear or obsolescence of laboratory equipment and technology infrastructure.

Ask your AI about Fulgent Genetics, Inc.'s laboratory services — d&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude